Ganciclovir Mono-O-acetate

Ganciclovir Mono-O-acetate, with the CAS number 88110-89-8, is a highly specialized and purified chemical compound that plays a crucial role in the field of antiviral research and development. This versatile molecule, derived from the parent compound Ganciclovir, offers unique properties that make it a valuable asset for scientists and researchers working to combat viral infections and diseases.

At its core, Ganciclovir Mono-O-acetate is a modified version of Ganciclovir, a well-known antiviral agent. The addition of the acetate group to the molecular structure of Ganciclovir results in a compound with enhanced stability and potential therapeutic applications. This structural alteration can lead to improved pharmacokinetic properties, increased bioavailability, and enhanced efficacy in targeting specific viral targets.

The chemical composition of Ganciclovir Mono-O-acetate, with the molecular formula C11H15N5O5 and a molecular weight of 297.27 g/mol, reflects its unique identity. The compound's IUPAC name, [2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxypropyl] acetate, provides a clear indication of its structural features, including the presence of the acetate group and the purine-based moiety derived from Ganciclovir.

Antiviral Applications

Ganciclovir Mono-O-acetate's primary application lies in the field of antiviral research and development. As a derivative of the well-established antiviral agent Ganciclovir, this compound holds the potential to exhibit enhanced antiviral activity against a range of viral infections. Researchers in the pharmaceutical and biotechnology industries may utilize Ganciclovir Mono-O-acetate as a starting material or intermediate in the synthesis of novel antiviral drugs, targeting conditions such as cytomegalovirus (CMV) infections, herpes simplex virus (HSV) infections, and other viral diseases.

The compound's unique structural features, including the acetate group and the purine-based moiety, may contribute to its ability to interfere with viral replication mechanisms or disrupt essential viral processes. By leveraging the properties of Ganciclovir Mono-O-acetate, researchers can explore new avenues for developing more effective and targeted antiviral therapies, ultimately improving patient outcomes and addressing unmet medical needs.

Product Specifications

• CAS Number: 88110-89-8
• Name: Ganciclovir Mono-O-acetate
• Reference Number: 86-MM0485.12
• Appearance: White Solid
• Melting Point: 133-135 °C
• Molecular Formula: C11H15N5O5
• Molecular Weight: 297.27 g/mol
• InChI: InChI=1S/C11H15N5O5/c1-6(18)20-3-7(2-17)21-5-16-4-13-8-9(16)14-11(12)15-10(8)19

Handling and Storage

Ganciclovir Mono-O-acetate should be handled with care, as it is classified as a compound with suspected genotoxic, carcinogenic, and reproductive toxicity properties. Appropriate personal protective equipment, such as gloves, lab coat, and safety glasses, should be worn when working with this compound. It is recommended to work in a well-ventilated area or under a fume hood to minimize exposure.

For long-term storage, Ganciclovir Mono-O-